Download Citation
Article Source:
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
Karbhari A,
Mosessian S,
Trivedi KH,
Valla F Jr,
Jacobson M,
et al.
(2023)
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
PLOS ONE 18(11): e0294564.
https://doi.org/10.1371/journal.pone.0294564